Vontobel Holding Ltd. Decreases Stock Holdings in SPDR S&P Biotech ETF $XBI

Vontobel Holding Ltd. lessened its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 83.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,230 shares of the exchange traded fund’s stock after selling 10,878 shares during the quarter. Vontobel Holding Ltd.’s holdings in SPDR S&P Biotech ETF were worth $223,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Capital A Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the second quarter worth about $26,000. DHJJ Financial Advisors Ltd. acquired a new position in SPDR S&P Biotech ETF in the second quarter valued at $25,000. Twin Peaks Wealth Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $32,000. Johnson Financial Group Inc. acquired a new position in shares of SPDR S&P Biotech ETF during the second quarter worth $31,000. Finally, AlphaCore Capital LLC boosted its stake in shares of SPDR S&P Biotech ETF by 6,650.0% in the second quarter. AlphaCore Capital LLC now owns 540 shares of the exchange traded fund’s stock valued at $45,000 after purchasing an additional 532 shares during the period.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $121.67 on Wednesday. The firm has a 50-day moving average of $117.58 and a two-hundred day moving average of $100.82. The stock has a market cap of $7.39 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $126.50.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.